Clinical Trials on Advanced NSCLC in United Kingdom
Total 3017 results
-
University of Kansas Medical Centerparkview cancer instituteRecruitingNSCLC Stage IV | NSCLC, RecurrentUnited States
-
Jun Zhang, MD, PhDUniversity of Iowa; University of KentuckyRecruitingNSCLC Stage IV | NSCLC Stage IIIBUnited States
-
University of WolverhamptonThe Royal Wolverhampton Hospitals NHS TrustRecruitingAdvanced Prostate CarcinomaUnited Kingdom
-
T-knife GmbHTerminatedAdvanced Solid TumorsGermany, Belgium, Spain, Netherlands, United Kingdom
-
Taiho Oncology, Inc.TerminatedAdvanced or Metastatic Solid Tumors Irrespective of Gene Alterations | Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating MutationsUnited States, United Kingdom, Austria, France
-
PfizerCompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Prostate Cancer | Advanced Solid Tumors | Solid TumorsUnited States, Australia
-
Joel NealNektar TherapeuticsCompletedTumors Metastatic to Brain | Stage IV Non-small Cell Lung Cancer (NSCLC) | Recurrent Non-small Cell Lung Cancer (NSCLC) | Extensive-stage Small Cell Lung Cancer (SCLC) | Recurrent Small Cell Lung Cancer (SCLC) | Metastatic Breast Cancer (mBC)United States
-
PfizerCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
Merus N.V.Chiltern International Inc.; Q2 Solutions; Oncology Therapeutic Development (OTD) and other collaboratorsRecruitingGastric Cancer | Colorectal Cancer | NSCLC | Head and Neck Squamous Cell Carcinoma | HNSCC | Advanced/Metastatic Solid Tumors | Gastroesophageal-junction CancerUnited States, Spain, Belgium, France, Netherlands, United Kingdom
-
ADC Therapeutics S.A.Active, not recruitingAdvanced Solid TumorsUnited States, Spain, United Kingdom
-
Immunocore LtdTerminatedSelect Advanced Solid TumorsUnited States, Canada, United Kingdom
-
Addario Lung Cancer Medical InstituteUniversity of Southern California; Ohio State University Comprehensive Cancer...Recruiting
-
Affimed GmbHRecruitingAdvanced Solid TumorUnited States, Spain, United Kingdom, Korea, Republic of, Poland
-
Taiho Oncology, Inc.TerminatedAdvanced Solid Tumors With HER2 Abnormalities | Advanced Solid Tumors With HER3 AbnormalitiesUnited States, Spain, France, United Kingdom
-
Merck KGaA, Darmstadt, GermanyActive, not recruiting
-
Imperial College LondonIncyte Biosciences UK LtdActive, not recruitingAdvanced Hepatocellular CarcinomaUnited Kingdom
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; National Institute for Health...Active, not recruiting
-
University of Alabama at BirminghamSanofiCompletedNon-small Cell Lung Cancer (NSCLC) | Metastatic NSCLC | Stage IV NSCLCUnited States
-
Chao HuangUniversity of Kansas Medical CenterActive, not recruitingAdvanced Solid Tumor | Non-small Cell Lung Cancer (NSCLC)United States
-
Calithera Biosciences, IncCompletedNSCLC | Solid Tumors | KRAS Gene Mutation | CRCUnited States
-
Janssen Research & Development, LLCActive, not recruitingAdvanced Solid MalignanciesUnited States, United Kingdom, Canada, Korea, Republic of
-
Merck Sharp & Dohme LLCTerminatedAdvanced Solid TumorsGermany, Spain, United Kingdom
-
InventisBio Co., LtdMerck Sharp & Dohme LLCActive, not recruitingNSCLC | Solid Tumor, Adult | CRCUnited States, Taiwan, Australia, Korea, Republic of
-
Novartis PharmaceuticalsTerminatedAdvanced Non Small Cell Lung Cancer (NSCLC)France, Italy, Taiwan, Spain, Netherlands, Japan, Hong Kong, Korea, Republic of, Norway, United States, United Kingdom, Poland
-
Royal Marsden NHS Foundation TrustCompletedLocally Advanced Larynx, Hypopharyngeal Squamous Cell Cancers | Locally Advanced Thyroid CancersUnited Kingdom
-
Polaris GroupTerminatedGlioma | Hepatocellular Carcinoma | Uveal Melanoma | Sarcomatoid Carcinoma | Pleural Mesothelioma Malignant Advanced | Peritoneal Mesothelioma Malignant Advanced | Non-squamous Non-small Cell Lung CarcinomaUnited States, United Kingdom
-
Repare TherapeuticsRoche Pharma AGActive, not recruitingAdvanced Solid TumorUnited States, Canada, Denmark, United Kingdom
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaActive, not recruitingAdvanced or Metastatic NSCLCUnited States, Spain, Taiwan, Japan, Italy
-
National Cancer Institute (NCI)RecruitingAdenocarcinoma | Advanced Non-Small Cell Lung Cancer | Squamous Cell Carcinoma | Advanced NSCLC | Adenosquamous CarcinomaUnited States
-
PfizerMerck Sharp & Dohme LLCTerminatedALK-positive Advanced NSCLCUnited States
-
University of EdinburghNHS LothianRecruitingQuality of Life | Advanced Cancer | Cachexia; CancerUnited Kingdom
-
The Netherlands Cancer InstituteEuropean UnionActive, not recruitingNSCLCUnited Kingdom, Denmark, Netherlands, Sweden, Belgium
-
Michelle MossaUniversity of LiverpoolCompletedLocally Advanced Rectal CancerUnited Kingdom
-
MedImmune LLCCompletedA Study of MEDI5395 in Combination With Durvalumab in Participants With Select Advanced Solid TumorsAdvanced Solid TumorsUnited States, United Kingdom
-
Vrije Universiteit BrusselKing's College London; University of Copenhagen; Erasmus Medical Center; University... and other collaboratorsActive, not recruitingAdvanced CancerBelgium, Netherlands, Denmark, Ireland, United Kingdom, Italy
-
Astellas Pharma IncOSI PharmaceuticalsCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
Royal Marsden NHS Foundation TrustNot yet recruitingAdvanced Prostate CarcinomaUnited Kingdom
-
Royal Marsden NHS Foundation TrustTerminatedAdvanced Colorectal CancerUnited Kingdom
-
Immunocore LtdTerminatedSelect Advanced Solid TumorsUnited States, United Kingdom, Spain
-
Case Comprehensive Cancer CenterTerminatedAdvanced (Stage IV) Non-small Cell Lung Cancer (NSCLC)United States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States, Spain, France, United Kingdom
-
KangLaiTe USATerminatedStage IV NSCLCUnited States
-
Bristol-Myers SquibbTerminatedAdvanced CancerUnited States, Netherlands, Australia, Belgium, Canada, Italy, United Kingdom
-
EQRx International, Inc.Terminated
-
Novartis PharmaceuticalsCompletedcMET-dysregulated Advanced Solid TumorsUnited States, Italy, Spain, United Kingdom, Greece, Belgium, Austria, Czechia
-
Royal Brompton & Harefield NHS Foundation TrustActive, not recruitingWeight Loss | Advanced Heart Failure | Cardiac CachexiaUnited Kingdom
-
Ellipses PharmaRecruitingAdvanced Solid TumorUnited States, Spain, United Kingdom
-
Royal Marsden NHS Foundation TrustCompletedAdvanced Pancreatic CancerUnited Kingdom
-
Carrick Therapeutics LimitedCompletedAdvanced Solid MalignanciesUnited States, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Germany, Thailand, France, Belgium, China, Argentina, Greece, Turkey, Malaysia, Portugal, Hungary, Brazil, United States, India